University Library
  • Login
A gateway to Melbourne's research publications
Minerva Access is the University's Institutional Repository. It aims to collect, preserve, and showcase the intellectual output of staff and students of the University of Melbourne for a global audience.
View Item 
  • Minerva Access
  • Medicine, Dentistry & Health Sciences
  • Melbourne Medical School
  • Microbiology & Immunology
  • Microbiology & Immunology - Research Publications
  • View Item
  • Minerva Access
  • Medicine, Dentistry & Health Sciences
  • Melbourne Medical School
  • Microbiology & Immunology
  • Microbiology & Immunology - Research Publications
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

    Chemical Synergy between lonophore PBT2 and Zinc Reverses Antibiotic Resistance

    Thumbnail
    Download
    Published version (2.277Mb)

    Citations
    Scopus
    Web of Science
    Altmetric
    11
    9
    Author
    Bohlmann, L; De Oliveira, DMP; El-Deeb, IM; Brazel, EB; Harbison-Price, N; Ong, C-IY; Rivera-Hernandez, T; Ferguson, SA; Cork, AJ; Minh-Duy, P; ...
    Date
    2018-11-01
    Source Title
    mBio
    Publisher
    AMER SOC MICROBIOLOGY
    University of Melbourne Author/s
    McDevitt, Christopher; Davies, Mark; Dougan, Gordon
    Affiliation
    Microbiology and Immunology
    Metadata
    Show full item record
    Document Type
    Journal Article
    Citations
    Bohlmann, L., De Oliveira, D. M. P., El-Deeb, I. M., Brazel, E. B., Harbison-Price, N., Ong, C. -I. Y., Rivera-Hernandez, T., Ferguson, S. A., Cork, A. J., Minh-Duy, P., Soderholm, A. T., Davies, M. R., Nimmo, G. R., Dougan, G., Schembri, M. A., Cook, G. M., McEwan, A. G., von Itzstein, M., McDevitt, C. A. & Walker, M. J. (2018). Chemical Synergy between lonophore PBT2 and Zinc Reverses Antibiotic Resistance. MBIO, 9 (6), https://doi.org/10.1128/mBio.02391-18.
    Access Status
    Open Access
    URI
    http://hdl.handle.net/11343/253316
    DOI
    10.1128/mBio.02391-18
    Abstract
    The World Health Organization reports that antibiotic-resistant pathogens represent an imminent global health disaster for the 21st century. Gram-positive superbugs threaten to breach last-line antibiotic treatment, and the pharmaceutical industry antibiotic development pipeline is waning. Here we report the synergy between ionophore-induced physiological stress in Gram-positive bacteria and antibiotic treatment. PBT2 is a safe-for-human-use zinc ionophore that has progressed to phase 2 clinical trials for Alzheimer's and Huntington's disease treatment. In combination with zinc, PBT2 exhibits antibacterial activity and disrupts cellular homeostasis in erythromycin-resistant group A Streptococcus (GAS), methicillin-resistant Staphylococcus aureus (MRSA), and vancomycin-resistant Enterococcus (VRE). We were unable to select for mutants resistant to PBT2-zinc treatment. While ineffective alone against resistant bacteria, several clinically relevant antibiotics act synergistically with PBT2-zinc to enhance killing of these Gram-positive pathogens. These data represent a new paradigm whereby disruption of bacterial metal homeostasis reverses antibiotic-resistant phenotypes in a number of priority human bacterial pathogens.IMPORTANCE The rise of bacterial antibiotic resistance coupled with a reduction in new antibiotic development has placed significant burdens on global health care. Resistant bacterial pathogens such as methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus are leading causes of community- and hospital-acquired infection and present a significant clinical challenge. These pathogens have acquired resistance to broad classes of antimicrobials. Furthermore, Streptococcus pyogenes, a significant disease agent among Indigenous Australians, has now acquired resistance to several antibiotic classes. With a rise in antibiotic resistance and reduction in new antibiotic discovery, it is imperative to investigate alternative therapeutic regimens that complement the use of current antibiotic treatment strategies. As stated by the WHO Director-General, "On current trends, common diseases may become untreatable. Doctors facing patients will have to say, Sorry, there is nothing I can do for you."

    Export Reference in RIS Format     

    Endnote

    • Click on "Export Reference in RIS Format" and choose "open with... Endnote".

    Refworks

    • Click on "Export Reference in RIS Format". Login to Refworks, go to References => Import References


    Collections
    • Minerva Elements Records [45689]
    • Microbiology & Immunology - Research Publications [1555]
    Minerva AccessDepositing Your Work (for University of Melbourne Staff and Students)NewsFAQs

    BrowseCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects
    My AccountLoginRegister
    StatisticsMost Popular ItemsStatistics by CountryMost Popular Authors